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Introduction
Toxic epidermal necrolysis (TEN) and Stevens-Johnson
syndrome (SJS) are rare, life-threatening mucocutaneous
diseases, usually attributable to drugs and infections
1).
Corticosteroids have been used in the management of TEN
for the last 30 years. Their use has been much debated and
remains controversial
2). TEN can occur in spite of high
dose of systemic corticosteroids
3). The psychiatric side
effects of corticosteroids can include headache, insomnia,
depression, and mood disorders (including bipolar and
manic states) with or without psychotic episodes
4). The
treatment of steroid-induced psychosis is to taper or dis-
continue the steroid. Antipsychotics including haloperidol,
chlorpromazine and risperidone were offered for the
treatment of steroid-induced psychosis
5).
This report is on an 11-year-old boy who was admitted
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with TEN. After receiving a full-dose of steroids, he
showed psychotic symptoms. We diagnosed him as steroid-
induced psychosis. We tapered steroid and initiated an
antipsychotic medication and intravenous immunoglobulin.
Then his symptoms dramatically improved.
Case report
An 11-year-old boy was admitted to the department of
pediatrics in our hospital with erythematous rashes over his
entire body. The skin lesions started from face and neck,
3 days before admission and expanded to trunk and extre-
mities. There were erythematous maculopapular rashes and
multiple vesicles on the trunk and on legs. Targetoid lesions
were observed at both palms and soles, accompanying
severe pain.
About 8 weeks prior to this admission, he had been ad-
mitted to our hospital with his first episode of nephrotic
syndrome. He had received high-dose steroid (Deflaza-
cort: Calcort
Ⓡ, 72 mg per day) for 8 weeks. Remission was
achieved during induction therapy and by maintaining the
use of steroids (Calcort
Ⓡ, 24 mg per day).
He did not receive any other medication during the 8
A case of steroid-induced psychosis in a child having
nephrotic syndrome with toxic epidermal necrolysis
Sae Yoon Kim, M.D., Jae Min Lee, M.D. and Yong Hoon Park, M.D.
Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea
= Abstract =
Toxic epidermal necrolysis (TEN) and Stevens Johnson syndrome (SJS) are rare, life-threatening mucocutaneous diseases, –
usually attributable to drugs and infections. Corticosteroids have been used in the management of TEN for the last 30
years. This remains controversial and is still much debated. TEN can occur despite administration of high doses of systemic
corticosteroids. The psychiatric side effects of corticosteroids can include headache, insomnia, depression, and mood dis-
orders with or without psychotic episodes. Steroid-induced psychosis is dealt with by tapering or discontinuing the steroid;
antipsychotics are also sometimes used. We report a case of an 11-year-old boy who was admitted with TEN. He had also
been diagnosed as having nephrotic syndrome in the past. Remission was achieved through induction therapy and by
maintaining the use of steroids. After a full-dose intravenous dexamethasone for TEN, he showed psychotic symptoms.
We diagnosed him as having steroid-induced psychosis. We tapered the steroid use and initiated an atypical antipsychotic
medication, olazapine and intravenous immunoglobulin (IV-IG). His symptoms dramatically improved and he was dis-
charged. (Korean J Pediatr 2010;53:437-441)
Key Words : Nephrotic syndrome, Toxic epidermal necrolysis, Steroid-induced psychosisSY Kim, JMin Lee, YH Park
- 438 -
weeks before this episode of cutaneous eruptions, except
for the Calcort
Ⓡ, and had no history of known drug allergies.
The patient denied any past psychiatric history, including
depressive or manic symptoms. There was no family his-
tory of psychiatric illness.
On this visit to our center, the patient did not have any
upper respiratory infection evidence like cough or rhinorr-
hea. His body temperature was 37.5 , heart rate 72/min, ℃
respiratory rate 30/min and blood pressure 120/80 mmHg.
During the physical examination, he had acute ill appea-
rance with entire body covered with erythematous macu-
lopapular rash. The neurological findings were negative
with intact sensory and motor functions.
All laboratory tests including, white blood cell, hemoglo-
bin, hemocrit, platelet, electrolytes, aspartate aminotrans-
ferase, alanine aminotransferase, blood urea nitrogen, crea-
tinine and albumin levels came out normal. The erythrocyte
sedmentation rate was 11mm/H and C-reactive protein
level was 0.415 mg/dL. The urinalysis findings were nor-
mal as well.
Investigation of the multiple vesicles located on the leg
showed a negative Tzanck test and a negative Nikolsky's
sign. Serologic tests for Mycoplasma pneumoniae and her-
pes simplex virus were negative. He had mild conjunctival
injection but ophthalmological examination did not reveal
any corneal lesions.
On the day of the admission, he was diagnosed with
erythema multiforme and he was put on the schedule of
maintained oral steroid (Calcort
Ⓡ, 24 mg per day). He re-
ceived conservative treatment for pain control, wet dres-
sing and topical steroid ointment for skin lesions.
On the fourth day of hospitalization, skin lesion was get-
ting worse with large bullaes and positive Nikolsky's sign
with severe pain.
On the eighth admission day, his skin lesions were diag-
nosed as toxic epidermal necrolysis (TEN) with skin ero-
sion and large bullae on the entire body.
On the ninth day, high-dose intravenous steroid (Dexa-
methasone) was tried for the patient, but symptoms were
intractable. On the following day, the patient developed
aggressive and hostile personality and behavioral changes.
He had psychotic symptoms with bizarre behavior, visual
and auditory hallucination. When he closed his eyes, hallu-
cinations appeared as a man trying to stab and torment
him, and his mother was seen as the tormentor. He was
unable to sleep.
We thus diagnosed him with steroid-induced psychotic
disorder and decreased the amount of steroids and initiated
a regimen of olanzapine (Zyprexa
Ⓡ). For the skin lesion, we
tried intravenous immunoglobulin (IV-IG) 3g/kg for 3 days
and supportive treatments were done. Because of his psy-
chotic reaction and refractory to steroid in the skin lesion,
we decided to start IV-IG.
Three days after starting the atypical antipsychotics drug,
his symptoms were improved dramatically. The only side
effect was mild sedation during daytime.
No abnormal findings were observed on urinalysis at any
time during his stay in hospital. He was discharged after
22 days of hospitalization. His skin lesions were showing
signs of recovery when he was released from the hospital.
Discussion
Toxic epidermal necrolysis (TEN) is a life-threatening
idiosyncratic adverse drug reaction characterized by full
thickness epidermal necrosis and evantual development of
subepidermal bullae
6). To date, there are no validated tests
to confirm the causative drug in these cases
1). There is no
particular treatment established for TEN
7).
The most commonly identified drugs are sulphonamide
antibiotics, with rates of up to 4.5 cases per million users
per week. Other antimicrobial agents include aminopenicil-
lins, quinolones, cephalosporins, tetracyclines and imidazole
antifungals. Frequent offenders also include anticonvulsant
agents, non-steroidal anti-inflammatory drugs and allopu-
rinol
1). Roujeau et al.
8) reported that exposure to corticos-
teroids significantly increased the risk of SJS or TEN,
altough the exact machanism is not known. This patient
visited the hospital with skin lesions, erythematous maculo-
papular rash, and multiple vesicles on the trunk and legs.
He was diagnosed with erythema multiforme (EM). It is
known that Mycoplasma pneumonia and herpes simplex
virus are common cause of EM, but initial serologic tests
were negative. He was put on the schedule of oral steroid
therapy and he was tried NSAIDs for pain relief.
It is now known that many cytokines have been found in
the involved epidermis. In particular, interleukin 6, tumor
necrosis factor (TNF)-alpha and Fas ligand (FasL) have
been shown to be highly expressed
9). Apoptotic keratino-
cytes become necrotic, and cohesion between adjacent ke-
ratinocytes and the basement membrane fails. The result
is loss of epidermal viability and separation at the level ofA case of steroid-induced psychosis in a child having nephrotic syndrome child with TEN
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the dermoepidermal junction
1).
The mortality of TEN is thought to be around 30%. The
most common cause of death is infection, particularly in-
volving Staphylococcus aureus, Pseudomonas aeruginosa
and Candida
10). In practice, on suspicion of a diagnosis, all
potential causative agents should be discontinued; this often
means that all drugs must be stopped. Immediate withdrawal
of the attributable drug is known to improve prognosis
1).
The most likely offending drug is one that has been newly
administered within 4 weeks of presentation
8).
Supportive therapy aims to limit the associated medical
complications, which are the main cause of death. Rigorous
adjustment of fluid, protein and electrolyte balance, strict
thermoregulation, control of infection, and regular surveil-
lance with sepsis screening are essential
6).
Corticosteroids have been used to manage TEN for the
last 30 years. Their use has been much debated and re-
mains controversial. Proponents emphasize the importance
of early intervention during the initial erythrodermic stage,
with high doses for a few days only, to inhibit inflamma-
tion
2). However, there is considerable suggestion from
previous studies that steroids may increase both morbidity
and mortality as a consequence of increased risk of sepsis
1). Kim et al.
7) reported a case of TEN caused by the use
of steroid with enalapril in a child suffering from nephrotic
syndrome. The reason for skin lesions not reappearing
after oral deflazacort was changed to oral prednisolone
after TEN remission, is not yet clear
7).
The use of IV-IG with potent anti-Fas activity has been
described previously in several case series for the treat-
ment of TEN with inconsistent results
11). In the original pilot
study, a series of 10 consecutive patients were treated with
intravenous immunoglobulin at 0.2-0.75 g/kg for 4 days.
In all patients, a rapid decrease in disease progression
was seen, and all patients recovered
12). There are reports
to suggest that plasmapheresis and haemodialysis may be
used to remove the causative drug and its toxic metabolites
from the circulation
13). In this case, full-dose intravenous
steroid was tried for the patient, and then he had psychotic
symptoms with bizarre behabior, visual and auditory hallu-
cination.
The psychiatric side effects of corticosteroids can include
headache, insomnia, depression, and mood disorders (in-
cluding bipolar and manic states) with or without psychotic
episodes
4). In an original report, Wada and colleagues
14)
described a case series of 18 patients (2,069 screened
patients) without prior psychiatric history, DSM-IV criteria
for corticosteroid-induced psychotic or mood disorder, and
symptoms persisting for at least 7 days. The prevalence of
symptoms among referred cases was less than one percent,
with 15 cases presented as mood disorders and 3 cases
presented as psychotic disorder. The majority of patients
demonstrated manic or bipolar symptoms and approximately
half demonstrated psychotic features
14).
Delirium is a serious neuropsychiatiric disorder caused
by a general medical condition or its treatment. It is cha-
racterized by an acute onset, fluctuating disturbances of
consciousness, and cognitive disturbances
15). The low cu-
mulative incidence of 5% is mainly the result of the low
incidence in the younger age groups (<9 year old). A clearly
higher incidence is seen in the total sample (80%)
16). In
critically ill adult patients substantially higher incidences
have been reported, ranging from 10-30% in general hos-
pital setting to 50% in postoperative patients and up to 80
% in the terminally ill
15). The differential diagnosis of pe-
diatric delirium consists of acute stress reactions, acute
anxiety states, adjustment disorders with mixed emotions,
dissociative and/or regressive states and childhood-onset
psychosis
16). Known risk factors are: severe illness, any
medical procedure, exposure to medication, notably poly-
pharmacy, malnutrition and dehydration
15).
The time course of pain relief is consistent with reported
onset of corticosteroid induced psychiatric symptoms
4). It
seems that higher doses of steroid predispose individuals
to suffer from psychiatric episodes, although it is unclear
if the dose impacts the development of phychosis specifi-
cally. From available evidence, the dose does not seem to
affect the rate of onset, duration, or severity
17).
Psychiatric symptoms have also been reported and these
can vary from mild mood changes to full blown psychosis.
Despite the lack of reports in the pain, literature, the cur-
rent case emphisizes the potential of corticosteroid induced
phychosis following multiple interventional pain procedures
performed in one session
4).
Whenever delirium was identified or suspected, a two-
track treatment approach consisting of both psychosocial
and pharmacological interventions was implemented
16). The
treatment of steroid-induced psychosis is to taper the ste-
roids to the lowest dose or to discontinue the medication
5).
In this case, corticosteroid had to be reduced to lower
dosage because of concomitant use of IV-IG. Lithium and
antipsychotics including haloperidol, chlorpromazine andSY Kim, JMin Lee, YH Park
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risperidone were offered for the treatment of steroid-
induced psychosis
5). Atypical and typical antipsychotics
are comparable in their clinical efficiency to some extent,
but they differ remarkably in regards to their side effect
profiles. Typical antipsychotics have more risk for develo-
ping extrapyramidal side effects (EPS) including dyskine-
sias and dystonias than atypicals
5). Purdon et al.
18) found a
greater cognitive benefit with olanzapine relative to halo-
peridol and risperidone. This also describes a significantly
greater proportion of patients taking haloperidol (73.3%)
required anticholinergic treatment relative to risperidone
(45%) and olanzapine (15%).
Children with nephrotic syndrome often experience se-
rious problems with depression, anxiety and increased
aggression during high-dose prednisone therapy
19). Lopez-
Medrano et al.
20) reported that higher levels of free and
active fraction of steroids along with low plasma albumin
levels will expose the patient to more adverse effects.
However, steroid-induced psychosis was developed during
remission of nephrotic syndrome in this patient.
In conclusion, an 11-year-old boy was admitted with
TEN and he had been diagnosed as nephrotic syndrome
already. Remission was achieved during induction therapy
and by maintaining the use of steroids. After full-dose
intravenous dexamethasone for TEN, he showed psychotic
symptoms. We diagnosed him as having steroid-induced
psychotic disorder. We reduced the amount of steroid and
initiated an antipsychotic medication and IV-IG. Then his
symptoms dramatically improved and he was discharged.
요 약
신증후군 환아에서 발생한 독성표피괴사용해
치료를 위해 사용된 고용량 스테로이드로
인한 정신질환 례 1
영남대학교 의과대학 소아과학교실
김세윤 이재민 박용훈 ㆍ ㆍ
독성표피괴사용해 와 스티븐 존슨 증후군 은 약물 (TEN) - (SJS)
이나 감염에 의해 발생하는 피부점막을 침범하는 드물지만 치명
적인 질병이다 스테로이드는 의 치료에 많이 이용되어왔지 . TEN
만 아직까지도 논쟁중이다 스테로이드에 의한 정신과적 영향은 , .
두통 불면증 우울증 심리질환 등이 있다 스테로이드에 의한 정 , , , .
신질환에서 치료는 스테로이드의 감량 또는 중단이고 항정신성 ,
약물을 투여한다 신증후군으로 진단된 세 남아에서 스테로이 . 11
드 치료 후 관해상태에서 유지치료를 시행하고 있던 중에 TEN
이 발생하였다 저자들은 이 환아에서 치료목적으로 투여한 고용 .
량 스테로이드 정맥주사로 인해 정신질환이 동반되었고 이후 스 ,
테로이드 감량과 항정신성 약물과 면역글로불린으로 증상이 호전
되는 것을 경험하여 이를 보고하는 바이다.
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